Metabolites
Displaying metabolites 2626 - 2650 of 3755 in total
Metabolite ID | Name CAS Number | IUPAC Name | SMPDB Pathways | Weight Formula | Structure |
---|---|---|---|---|---|
ECMDB24647 | CDP-DG(12:0(3-OH)/14:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-3-[(3-hydroxydodecanoyl)oxy]-2-(tetradecanoyloxy)propoxy]phosphoryl}oxy)phosphinic acid | phospholipid biosynthesis (CL(12:0(3-OH)/14:0/12:0(3-OH)/14:0)) PW001919 | 885.923 C38H69N3O16P2 | |
ECMDB24657 | CDP-DG(12:0/14:0(3-OH)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(dodecanoyloxy)-2-[(3-hydroxytetradecanoyl)oxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | phospholipid biosynthesis (CL(12:0/14:0(3-OH)/12:0/14:0(3-OH))) PW001931 | 885.923 C38H69N3O16P2 | |
ECMDB24661 | CDP-DG(14:0(3-OH)/12:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-(dodecanoyloxy)-3-[(3-hydroxytetradecanoyl)oxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | phospholipid biosynthesis (CL(14:0(3-OH)/12:0/14:0(3-OH)/12:0)) PW001935 | 885.923 C38H69N3O16P2 | |
ECMDB24667 | CDP-DG(14:0/12:0(3-OH)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(3-hydroxydodecanoyl)oxy]-3-(tetradecanoyloxy)propoxy]phosphoryl}oxy)phosphinic acid | phospholipid biosynthesis (CL(14:0/12:0(3-OH)/14:0/12:0(3-OH))) PW001943 | 885.923 C38H69N3O16P2 | |
ECMDB24683 | CDP-DG(16:0/10:0(3-OH)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(3-hydroxydecanoyl)oxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | phospholipid biosynthesis (CL(16:0/10:0(3-OH)/16:0/10:0(3-OH))) PW001949 | 885.923 C38H69N3O16P2 | |
ECMDB24320 | PGP(19:0/19:0) | [(2R)-3-({[(2R)-2,3-bis(nonadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2-hydroxypropoxy]phosphonic acid | phospholipid biosynthesis (CL(18:1(11Z)/19:0/19:0/19:0)) PW001981 | 887.123 C44H88O13P2 | |
ECMDB24410 | PGP(19:iso/19:iso) | [(2S)-3-({[(2R)-2,3-bis[(17-methyloctadecanoyl)oxy]propoxy](hydroxy)phosphoryl}oxy)-2-hydroxypropoxy]phosphonic acid | phospholipid biosynthesis (CL(19:iso/19:iso/19:iso/19:iso)) PW002009 | 887.123 C44H88O13P2 | |
ECMDB20104 | 5-Methyl-3-oxo-4-hexenoyl-CoA | 4-({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-3,3-dimethyl-N-[2-({2-[(5-methyl-3-oxohex-4-enoyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)ethyl]butanimidic acid | 891.671 C28H44N7O18P3S | ||
ECMDB03949 | (2E)-Octenoyl-CoA 10018-94-7 | {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy(3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2E)-oct-2-enoylsulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy)phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid | 891.714 C29H48N7O17P3S | ||
ECMDB24014 | 3-O-Sulfogalactosylceramide (d18:1/24:0) | [(2R,3R,4S,5S,6R)-3,5-dihydroxy-2-{[(2S,3R,4E)-3-hydroxy-2-tetracosanamidooctadec-4-en-1-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxidanesulfonic acid | 892.317 C48H93NO11S | ||
ECMDB20101 | 5-Carboxy-2-pentenoyl-CoA 138149-18-5 | (4E)-6-({2-[(3-{[4-({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-1,2-dihydroxy-3,3-dimethylbutylidene]amino}-1-hydroxypropylidene)amino]ethyl}sulfanyl)-6-oxohex-4-enoic acid | Phenylalanine metabolism PW000921 | 893.644 C27H42N7O19P3S | |
ECMDB23163 | 2,3-dehydroadipyl-CoA | (4E)-6-[(2-{3-[(2R)-3-[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-2-hydroxy-3-methylbutanamido]propanamido}ethyl)sulfanyl]-6-oxohex-4-enoic acid | 893.644 C27H42N7O19P3S | ||
ECMDB20071 | 3-Hydroxy-5-methylhex-4-enoyl-CoA | 4-({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-N-[2-({2-[(3-hydroxy-5-methylhex-4-enoyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)ethyl]-3,3-dimethylbutanimidic acid | 893.687 C28H46N7O18P3S | ||
ECMDB20539 | Crotonobetainyl-CoA | [(2E)-4-({2-[(3-{[(2R)-4-({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-1,2-dihydroxy-3,3-dimethylbutylidene]amino}-1-hydroxypropylidene)amino]ethyl}sulfanyl)-4-oxobut-2-en-1-yl]trimethylazanium | L-carnitine degradation I PW002037 | 893.71 C28H48N8O17P3S | |
ECMDB23848 | (E)-4-(Trimethylammonio)but-2-enoyl-CoA | [(2E)-4-({2-[(3-{[(2R)-4-({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-1,2-dihydroxy-3,3-dimethylbutylidene]amino}-1-hydroxypropylidene)amino]ethyl}sulfanyl)-4-oxobut-2-en-1-yl]trimethylazanium | 893.71 C28H48N8O17P3S | ||
ECMDB01070 | Octanoyl-CoA 1264-52-4 | {[5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({[hydroxy({3-hydroxy-2,2-dimethyl-3-[(2-{[2-(octanoylsulfanyl)ethyl]carbamoyl}ethyl)carbamoyl]propoxy})phosphoryl]oxy})phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid | 893.73 C29H50N7O17P3S | ||
ECMDB21192 | CDP-1,2-ditetradec-7-enoylglycerol | [({[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy][(2R)-2,3-bis[(7Z)-tetradec-7-enoyloxy]propoxy]phosphinic acid | 893.9345 C40H69N3O15P2 | ||
ECMDB20073 | 3-Hydroxy-5-oxohexanoyl-CoA | (2R)-4-({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-N-[2-({2-[(3-hydroxy-5-oxohexanoyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)ethyl]-3,3-dimethylbutanimidic acid | Aminobenzoate Degradation PW000757 | 895.66 C27H44N7O19P3S | |
ECMDB20559 | gamma-Butyrobetainyl-CoA | [4-({2-[(3-{[4-({[({[5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-1,2-dihydroxy-3,3-dimethylbutylidene]amino}-1-hydroxypropylidene)amino]ethyl}sulfanyl)-4-oxobutyl]trimethylazanium | L-carnitine degradation I PW002037 | 895.726 C28H50N8O17P3S | |
ECMDB23901 | 4-Trimethylammoniobutanoyl-CoA | {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-2,2-dimethyl-3-({2-[(2-{[4-(trimethylazaniumyl)butanoyl]sulfanyl}ethyl)carbamoyl]ethyl}carbamoyl)propoxy]phosphoryl}oxy)phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid | 895.73 C28H50N8O17P3S | ||
ECMDB23329 | CDP-DG(10:0/18:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(decanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | phospholipid biosynthesis CDP-DG(10:0/18:1(9Z)) PW001756 | 895.962 C40H71N3O15P2 | |
ECMDB23335 | CDP-DG(12:0/16:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(dodecanoyloxy)-2-[(9Z)-hexadec-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | 895.962 C40H71N3O15P2 | ||
ECMDB23363 | CDP-DG(16:1(9Z)/12:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-(dodecanoyloxy)-3-[(9Z)-hexadec-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | phospholipid biosynthesis (PE(16:1(9Z)/12:0(3-OH))) PW001755 | 895.962 C40H71N3O15P2 | |
ECMDB23376 | CDP-DG(18:1(9Z)/10:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-(decanoyloxy)-3-[(9Z)-octadec-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | phospholipid biosynthesis (PE(18:1(9Z)/10:0(3-OH))) PW001779 | 895.962 C40H71N3O15P2 | |
ECMDB24708 | CDP-DG(18:1(11Z)/10:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-(decanoyloxy)-3-[(11Z)-octadec-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | phospholipid biosynthesis (CL(18:1(11Z)/10:0/10:0/10:0)) PW001976 | 895.962 C40H71N3O15P2 |